Immune thrombocytopenia (ITP)
Clinical trials for Immune thrombocytopenia (ITP) explained in plain language.
Never miss a new study
Get alerted when new Immune thrombocytopenia (ITP) trials appear
Sign up with your email to follow new studies for Immune thrombocytopenia (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a gut bacteria transplant help when steroids fail for a bleeding disorder?
Disease control OngoingThis phase 2 trial tests whether fecal microbiota transplantation (FMT) — transferring gut bacteria from a healthy donor — can help adults with chronic immune thrombocytopenia (ITP) whose disease has not responded to or has relapsed after steroid treatment. Participants will rece…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase 2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New drug RAY121 tested for Long-Term control of autoimmune diseases
Disease control By invitation onlyThis study is a long-term extension of an earlier trial, testing the safety of a drug called RAY121 in people with six different immune system disorders, including antiphospholipid syndrome and immune thrombocytopenia. Participants have already completed four doses of RAY121 and …
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase 1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Will a new drug form work the same? study tests two versions of SKI-O-703
Knowledge-focused OngoingThis study tests whether two different capsule forms of the experimental drug SKI-O-703 are absorbed similarly in the body. About 48 healthy adults (Korean and Caucasian) will take a single dose of each form on separate days, with blood samples taken to compare drug levels. The r…
Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)
Phase 1 • Sponsor: Oscotec Inc. • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC